PROLACTIN HETEROGENEITY - A LIMITATION ON THE EVALUATION OF RESULTS FROM PROLACTIN ASSAYS DUE TO DIFFERENCES IN IMMUNOASSAYS AND THE DIFFERENT BIOACTIVITIES OF PROLACTIN FORMS
B. Lohrke et al., PROLACTIN HETEROGENEITY - A LIMITATION ON THE EVALUATION OF RESULTS FROM PROLACTIN ASSAYS DUE TO DIFFERENCES IN IMMUNOASSAYS AND THE DIFFERENT BIOACTIVITIES OF PROLACTIN FORMS, European journal of clinical chemistry and clinical biochemistry, 31(12), 1993, pp. 815-827
Prolactin exists in biological fluids in several molecular forms. This
raises two questions: (1) whether the assay of prolactin by immunotec
hniques is valid and reliable and (2) whether the different forms have
different physiological roles, which might be exploited to improve di
agnostic accuracy and data interpretation by the use of appropriate me
thods. To investigate these questions, prolactin from human amniotic f
luid was separated, by concanavalin A-Sepharose affinity chromatograph
y, into bound, retarded and unbound fractions (bound prolactin fractio
n, retarded prolactin fraction, unbound prolactin fraction), which wer
e characterized by electrophoresis, immunoblotting and glycan detectio
n blot. Virtually no contamination was found in the bound prolactin fr
action, and the unbound prolactin fraction and retarded prolactin frac
tion were 74-83% pure according to densitometry of the electrophoretic
and immunoblot patterns. High variability was found among the individ
ual patterns. Glycan detection in the blotted fractions revealed that
the bound prolactin fraction bands corresponding to M(r) 25000 - 29000
were weakly glycolysated, whereas the bands of M(r) 60000 - 64000 wer
e significantly glycan-positive. Immunoreactive bands of unbound prola
ctin fraction and retarded prolactin fraction also stained positively
for glycans. Using two commercial prolactin kits, the bound prolactin
fraction forms were virtually undetectable. To demonstrate that the pr
olactin forms may depend on the hypothalamic state, two behaviourly di
fferent breeds of cattle were used as an animal model for studying hyp
othalamic activities. The number of immunoreactive bands, representing
the prolactin forms, and the change of the forms in response to thyro
liberin differed strikingly among the groups. The bioactivity of the f
orms was examined in bovine granulosa, oviductal, endometrial and sple
en cells, and in murine splenocytes, the latter being activated by con
canavalin A or allogeneically to create in vitro conditions that may h
ave relevance for situations in vivo. The rate of incorporation of [H-
3]thymidine in murine splenocytes was dose-dependently enhanced only b
y bound prolactin fraction. The increase was abolished by purified ant
i-prolactin antiserum. However, the standard prolactin from the kits i
nhibited the proliferation even in low dose (1.25 mu g/l) and the inhi
bition was abolished in part by bound prolactin fraction. Thymidine in
corporation into the bovine cells was significantly increased by low c
oncentrations (2 mu g/l) of unbound prolactin fraction and retarded pr
olactin fraction. Oviduct epithelial cells and splenocytes were stimul
ated by unbound prolactin fraction but not by retarded prolactin fract
ion in a dose of 16 mu g/l. Thymidine incorporation into granulosa cel
ls was inhibited by retarded prolactin fraction (16 mu g/l) but not by
unbound prolactin fraction.